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Preface 
 
This thesis is submitted for the degree of Doctor of Philosophy (PhD) to the 
Faculty of Pharmaceutical Life Sciences, University of Toyama, Japan. This work 
was carried out in the Division of Pathogenic Biochemistry, Institute of Natural 
Medicine. The results within this thesis were published in two papers as follow: 
 
1) Mesenchymal-transitioned cancer cells instigate the invasion of 
epithelial cancer cells through the secretion of WNT3 and WNT5B, Kato 
S, Hayakawa Y, Sakurai H, Saiki I, Yokoyama S, Cancer Sci., 2014, in 
press 
 
2) Procyanidin C1 from Cinnamomi Cortex inhibits TGF--induced 
epithelial-to-mesenchymal transition in the A549 lung cancer cell line, 
Kin R, Kato S, Kaneto N, Sakurai H, Hayakawa Y, Li F, Tanaka K, Saiki I, 
Yokoyama S, Int. J Oncol., 2013; 43(6): 1901-1906 
 
※All the data in chapter 2 is unpublished and in preparation for submission in 
2014, March.   
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The thesis is divided into three chapters: 
We focus on the tumor heterogeneity of mesenchymal-transitioned cancer cells 
(M-cell) within tumor microenvironment and the role of the cross-talk between 
M-cell and surrounding cancer cells during tumor malignant progression. 
Chapter 1 identifies the cross-talk with TGF--induced M-cell instigates 
the invasion and metastasis of epithelial cancer cells (E-cell) through the 
secretion of WNT3 and WNT5B. This finding highlights the significance of cancer 
heterogeneities and the interaction between E- and M-cells within tumor 
microenvironment in promoting metastatic disease through WNT-dependent 
mechanism. 
Chapter 2 focuses on the cross-talk between M-cells each other. Since 
the data in chapter 2 is unpublished March, 2014 now, chapter 2 is going to 
disclose when this study is published. 
Regarding to chapter 1 and 2, TGF--induced M-cell promotes tumor 
malignancy by mediating the cross-talk between surrounding E- and M-cells. 
The aim of chapter 3 is exploration of an active component which prevents 
TGF--induced EMT from a Japanese traditional medicine, Juzentaihoto. 
Procyanidin C1, from Cinnamoni Crtex, is newly characterized as an inhibitor of 
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TGF--induced EMT. 
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Chapter 1: Mesenchymal-transitioned cancer cells instigate the invasion of 
epithelial cancer cells through secretion of WNT3 and WNT5B. 
 
1. Abstract 
Although the heterogeneities of epithelial and mesenchymal-transitioned cancer 
cells are often observed within tumor microenvironment, the biological 
significance of interaction between epithelial cancer cells and 
mesenchymal-transitioned cancer cells is not yet understood. In this study, we 
showed that the mesenchymal-transitioned cancer cells instigate the invasive 
ability and metastatic potential of the neighboring epithelial cancer cells in vitro 
and in vivo. We further identified WNT3 and WNT5B as critical factors secreted 
from TGF--induced mesenchymal cancer cells for instigating to epithelial 
cancer cell invasion along with the induction of secondary-EMT phenotype. 
These results shed the light on the significance of cancer heterogeneities and 
the interaction between epithelial and mesenchymal-transitioned cancer cells 
within tumor microenvironment in promoting metastatic disease through 
WNT-dependent mechanism. 
Key Words: EMT, heterogeneity, cross-talk, WNT, metastasis 
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2. Introduction 
 
Tumor tissue consists of not only cancer cells, but also various stromal cells 
such as cancer-associated fibroblasts (CAFs), immune inflammatory cells, 
myeloid progenitor cells and vascular endothelial cells [1]. Such heterogeneity of 
complicated environment within tumor tissue has been considered as the tumor 
microenvironment and known to play important roles in cancer malignant 
progression [1]. Recent evidences further suggest that not only the tumor 
microenvironment but also cancer cells themselves within tumor tissue are also 
heterogeneous by representing numerous subpopulations with both genetic and 
non-genetic variations [2, 3]. 
Cancer metastasis disease, one of the major causes of the high mortality 
rate in cancer patients, involves multiple biological steps such as intravasation, 
attachment to vessel, extravasation, angiogenesis, and subsequent growth in 
distal tissues to primary tumor. Amongst those steps, the initial acquisition of 
cellular invasiveness is likely key steps of metastatic disseminations from the 
primary tumor site and the process called epithelial-to-mesenchymal transition 
(EMT) is known to play an important role during this process [4-7]. In accordance 
with the dynamic yet transient morphological and phenotypic alteration of cancer 
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cells during EMT process, such mesenchymal-transitioned cancer cells are often 
seen at an invasive front of a tumor tissue by neighboring epithelial cancer cells 
[8-13]. Even though the importance of TGF- in the initiation of EMT has been 
shown [14, 15], there are several reports that primary cancer specimens acquire 
mesenchymal features and develop metastatic disease even in the presence of 
the deletion in Smad4 which is a key component of TGF- signaling pathway [16, 
17]. These observations might imply that there are alternative pathways to 
maintain the EMT phenotype other than TGF- pathway within tumor 
microenvironment. Interestingly, the cooperation of mesenchymal-transitioned 
and surrounding epithelial cancer cells for establishing spontaneous metastasis 
in a mouse model was reported [18]. It was also studied that the heterogeneity of 
cancer cells and the intra-tumoral cross-talk between distinct types of cancer 
cells might contribute to induce abnormal proliferation and metastasis [19-21], 
however the exact mechanism how those distinct cancer cell types interact with 
each other is not yet understood. 
In the present study, we demonstrated that the co-existence of 
mesenchymal-transitioned cancer cells with epithelial cancer cells induces 
invasive ability and metastatic potential of epithelial cancer cells in vitro and in 
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vivo. Furthermore, we identified WNT3 and WNT5B are the secretory factors 
from TGF--induced mesenchymal-transitioned cancer cells to induce invasion 
of neighboring epithelial cancer cells and secondary-EMT phenotype. 
Collectively, those results strongly implicate that secretory WNT ligands are 
critical soluble factors to mediate invasion instigation of epithelial cancer cells 
derived from mesenchymal-transitioned cancer cells and further targeting those 
secretory WNT proteins could be a new approach to prevent cancer invasion 
and subsequent metastasis. 
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3. Materials and Methods 
 
3.1 Cell culture and inhibitors 
Human lung adenocarcinoma A549 and human pancreatic ductal 
adenocarcinoma Panc-1 cells were obtained from American Type Culture 
Collection (ATCC). A549 cells were maintained in RPMI1640, and Panc-1 cells 
were maintained in DMEM, containing 10% FBS, 1 mM L-glutamine and 
antibiotics (100 units/mL penicillin and 100 mg/mL streptomycin) in a humidified 
atmosphere of 95% air and 5% CO2 at 37°C. To establish labeled A549 and 
Panc-1 cells, A549 or Panc-1 cells were transfected with pGL4.50/Luc2 
(Promega, Madison, WI, USA) or pEGFP-C1 (Clontech, Palo Alto, CA, USA), 
selected, and cloned in growth medium containing 200 g/ml hygromycin B or 1 
mg/ml G418, respectively. The reagents used were: WNT secretion inhibitor, 
IWP-2 (Sigma-Aldrich) and TGF- receptor kinase inhibitor (TRI) (Calbiochem, 
Dermstadt, Germany).  
 
3.2 Preparation of E-cells and M-cells 
Non-stimulated epithelial A549 and Panc-1 cells were used as E-cells in this 
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study. To prepare mesenchymal-transitioned cancer cells (M-cells), A549 or 
Panc-1 cells were treated with 5 ng/ml recombinant TGF-(Pepro Tech, New 
Jersey, USA) for 48 hr then washed with fresh culture medium twice and 
harvested for subsequent experiments. 
 
3.3 Direct and separated co-culture experiment 
For direct co-culture experiment, E-cells and M-cells were re-seeded into 60 mm 
culture dish by indicated cell number and co-cultured for 24 hr. For separated 
co-culture experiment, 1x105 cells of E-cells and 3x105 cells of M-cells were 
seeded into lower or upper compartment of transwell chamber with 1 m pore 
diameter (BD Falcon, Bedford, MA, USA) for 24 h. 
 
3.4 Generation of conditioned medium (CM) 
After preparation of E- or M-cells, the cells were further cultured in fresh growth 
medium for additional 48 hr. Finally, these culture supernatants were collected 
and diluted with fresh growth medium by 2:1. The freshly prepared supernatant 
was utilized as conditioned medium (CM) in each experiment. 
For preparation of WNT3- and WNT5B-depleted CM by siRNA, parental 
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A549 and Panc-1 cells were transfected with siControl (siGENOME Control Pool 
Non-targeting siRNA#2), siWNT3 and/or siWNT5B (ON-TARGETplus 
SMARTpool siRNA) (Thermo Fisher scientific) by LipofectamineTM RNAiMAX 
(Invitrogen) 48 hr prior to induction of M-cells. For preparation of WNTs-depleted 
CM by IWP-2, E- and M-cells were cultured in fresh medium containing IWP-2 
for 48 hr. The protein level of WNT3 and WNT5B in CMs was determined by 
specific ELISA (CUSABIO Biotech Co., Ltd., Wuhan, China) according to 
manufacturer’s protocol. 
 
3.5 Matrigel invasion assay 
Cancer cell invasion through reconstituted basement membrane (Matrigel; BD 
Biosciences) was assayed as previously described [22]. After fixed the filter and 
stained with hematoxylin and eosin, the invaded cells were counted manually 
under a microscope at x100. For detection of luciferase activity in invaded 
A549/Luc2 cells, the filters were soaked into passive lysis buffer (Promega) and 
luciferase activity was determined. For detection of EGFP+ invaded cells, filters 
were fixed with 4% paraformaldehyde and stained with VECTASHIELD 
mounting media with DAPI (Vector Laboratories, Burlingame, CA).  
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3.6 Western blotting 
Whole cell lysates and nuclear protein extracts were prepared as described 
previously [23]. Primary antibodies used were Epithelial-Mesenchymal transition 
(EMT) Antibody Sampler Kit (#9782, Cell Signaling Technology), antibodies 
against WNT3 (ab32249) and WNT5B (ab94914) from Abcam, and antibodies 
against PCNA (PC10), -actin (C11), Lamin B (C-20), and -tubulin (D-10) from 
Santa Cruz biotechnology. 
 
3.7 Experimental lung metastasis experiment (in vivo invasion assay) 
C.B-17/lcrHsd-Prkdcscid mice were purchased from Japan SLC Inc. (Hamamatsu, 
Japan). All experiments were approved and performed according to the 
guidelines of the Care and Use of Laboratory Animals of University of Toyama. 
Cells were inoculated intravenously (2x106 cells/200 l PBS/mouse) into mice 
and the lungs were removed 24 hr after the tumor inoculation. Mice were 
intra-peritonealy injected with 200 l of luciferin (1.5 mg/ml, VivoGloTM, Promega, 
Madison, WI, USA) 20 min prior to subject bioluminescent assay by using an in 
vivo imaging system (IVIS Lumina II, Caliper Life Sciences, Hopkinton, MA, 
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USA). The data was presented as the mean luminescence ± SEM. 
 
3.8 Microarray data analysis 
The data sets (GSE17708 and GSE23952) were reanalyzed on GenePattern 
[24]. Briefly, the differential expression level of all genes between TGF--treated 
samples and non-treated samples was computed and the top 5% upregulated 
genes in TGF--treated cells compared with control cells were selected by using 
“Comparative Marker Selection” tool from each data set. Finally, the genes 
coding the secreted proteins were picked up from the commonly upregulated 
genes in both data sets. 
Gene set enrichment analysis (GSEA) was performed using javaGSEA 
application v2.0.13 (GSEA, Broad Institute, Boston). These pathway gene sets 
were provided by the Molecular Signatures Database (MSigDB; 
www.broadinstitute.org/gsea/msigdb). 
 
3.9 Quantitative RT-PCR 
Total RNA was purified using RNeasy plus mini kit (QIAGEN) and then 50 ng 
RNA of each sample was amplified using the One Step SYBR PrimeScript 
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RT-PCR kit (TaKaRa) and appropriate primers. The primers used were: 5’-TGT 
GAG GTG AAG ACC TGC TG-3’ (sense) and 5’-AAA GTT GGG GGA GTT CTC 
GT-3’ (antisense) for WNT3 and 5’-ACG CTG GAG ATC TCT GAG GA-3’ 
(sense) and 5’-CGA GGT TGA AGC TGA GTT CC-3’ (antisense) for WNT5B. 
 
3.10 Statistical analysis 
Statistical significance was calculated using Excel software (Microsoft). More 
than three means were composed using one-way analysis of variance (ANOVA) 
with Bonferroni correction, and two means were composed using unpaired 
Student’s t-test. p<0.05 were considered statistically significant. 
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4. Results 
 
4.1 Epithelial cancer cells acquire metastatic potential by the co-culture 
with mesenchymal-transitioned cancer cells. 
To directly evaluate the role of heterogeneity of cancer cells in their invasive 
potentials, we performed Matrigel invasion assay in human epithelial lung 
adenocarcinoma A549 and pancreatic ductal adenocarcinoma Panc-1 cell 
co-culture at various ratios of epithelial cancer cells (E-cells) and TGF--induced 
mesenchymal-transitioned cancer cells (M-cells), because A549 and Panc-1 are 
previously reported to be occurred EMT by the stimulation with TGF-(Fig. 1), 
which is the most potent EMT-inducing cytokine secreted from 
cancer-associated fibroblast and cancer cells [25, 26]. After 24 hr co-culture of 
E- and M-cells, the invasive potentials of E- and M-cells mixture were enhanced 
in both A549 and Panc-1 cell lines in M-cell dose-dependent manner than that of 
M-cells alone (Fig. 2A). To determine exact cell population, E- or M-cells, is 
responsible for the enhanced invasive potential after the co-culture, we 
employed luminescence-labeled E-A549 (E-A549/Luc2) or fluorescent-labeled 
E-Panc-1 (E-Panc/EGFP) to distinguish E-cells from M-cells within the co-culture. 
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By measuring the invasiveness of labeled E-cells in either A549 or Panc-1, we 
have found that the invasive potentials of E-cells co-cultured with M-cells were 
higher than that of E-cells alone in both A549 and Panc-1 (Fig. 2B) and such 
induction of invasiveness was observed in M-cell dose-dependent manner (Fig. 
2B). We have also found that the invasion potential of E-cells was not altered 
without the co-culture with M-cells (Fig. 2C). Of note, the invasive potential of 
M-Panc cells was not affected by the co-culture with E-Panc cells as compared 
with M-Panc cells alone (data not shown). These results clearly indicate that the 
co-culture of E-cells with M-cells selectively enhances the invasiveness of 
E-cells in both A549 and Panc-1 cell lines.  
 
Figure 1. Expression of EMT-related proteins following TGF--induced EMT. 
A549 and Panc-1 cells were treated with 5 ng/ml TGF- up to 72 hr. EMT-related 
protein expression were determine by western blotting. 
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Figure 2. Epithelial cancer cells acquire metastatic potential upon co-culture with 
mesenchymal-transitioned cancer cells. 
(A) A549 (left) or Panc-1 (right) cells were subjected to Matrigel invasion assay after 24 
hr-co-culture of epithelial cancer cells (E-cells) with mesenchymal-transitioned cancer 
cells (M-cells) at the indicated cell numbers. Total invaded cells were counted after H & 
E staining. Data represented as the mean ± SD of four independent experiments. (B) 
Labeled E-cells (E-A549/Luc2; left panel or E-Panc/EGFP; right panel) were subjected 
to Matrigel invasion assay after 24 hr-co-culture with M-cells. Invasive abilities were 
determined by measuring luciferase activity (A549) or counting invaded EGFP+ cells 
(Panc-1), respectively. Invasion ratio was calculated by the division of invaded E-cells by 
total E-cells applied. Data represented as the mean ± SD of triplicate experiment. 
*p<0.05, **p<0.01 vs E-cells alone group by Dunnett’s 
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To further investigate the significance of the interaction between E-cells 
and M-cells in vivo, the metastatic potentials of E-A549 cells to lung were 
examined by injecting E-A549/Luc2 cells upon co-culture with either E-A549 or 
M-A549 for 24 hr. The metastatic spread of E-A549/Luc2 in the lung were much 
higher after the co-culture with M-A549 cells compared to with E-A549 cells (Fig. 
2D), therefore indicating the potential of M-cells to promote metastatic ability of 
neighboring E-cells in vivo.  
 
Figure 2. Epithelial cancer cells acquire metastatic potential upon co-culture 
with mesenchymal-transitioned cancer cells. (continued) 
(C) To check whether the decrease of seeded cell number itself affect invasion 
potentials, E-A549 or E-Panc cells were subjected to matrigel invasion assay at 
indicated cell numbers. Invasion potentials were calculated based on the following 
formulation. (Invasion potential) = (invaded cell numbers) / (seeded cell numbers). 
Data represented as the mean ± SD of triplicate experiment. 
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Figure 2. Epithelial cancer cells acquire metastatic potential upon co-culture 
with mesenchymal-transitioned cancer cells. (continued) 
(D) Epithelial A549 cells overexpressing Luc2 gene (E-A549/Luc2) were 
co-cultured with either epithelial A549 (E-A549) cells or mesenchymal-transitioned 
A549 (M-A549) cells and i.v. inoculated into mice. Mice were sacrificed 24 hr after 
the tumor inoculation and lungs were subjected to bioluminescent imaging to 
determine total flux (photon/sec) for lung metastasis quantification. The 
representative ex vivo images are shown. Data represented as the mean ± SEM 
(n=5). 
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4.2 Mesenchymal-transitioned cancer cells induce metastatic potential of 
the neighboring epithelial cancer cells in cell-cell contact independent 
mechanism. 
To determine whether the direct cell-cell interaction is required for promoting 
metastatic potential of E-cells by neighboring with M-cells, we first examined the 
expression of EMT-related proteins in A549 or Panc-1 cells under the co-culture 
of E-cells with M-cells in the presence or absence of direct cell-cell contact (Fig. 
3A and 3B). Given the up-regulation of mesenchymal marker (Snail and 
Vimentin) and the down-regulation of epithelial marker (E-cadherin) were 
markedly induced by both direct and separated co-culture of E- and M-cells, the 
soluble factor(s) derived from M-cells was at least sufficient for the induction of 
secondary-EMT phenotype of E-cells upon co-culture with M-cells. Vimentin has 
two isoforms (full-length and C-terminal-deletion form) that show distinct roles on 
the bundle formation, subsequent cell morphology and motility (Chou YH, et al, J. 
Cell Sci., 1996; 109: 817-826). In this study, both vimentin isoforms were 
up-regulated by the treatment with M-CM, and indeed affect functional 
phenotypes of E-cells. We further confirmed that the invasion of E-A549 cells 
was remarkably enhanced after the culture with M-A549-derived conditioned 
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medium (M-A549-CM) compared with E-A549-CM (Fig. 3C). In concert with the 
enhanced invasive ability of E-A549 cells after the cultivation with M-A549-CM, 
the secondary-EMT phenotype in E-A549 cells were also induced after the 
culture with M-A549-CM. Similar results were obtained in the invasion of E-Panc 
cells after the cultivation with M-Panc-CM (Fig. 3D). 
Importantly, the CM from M-Panc cells was able to introduce enhanced 
invasive ability and secondary-EMT phenotype in E-A549 cells (Fig. 3E) 
indicating the common soluble factor(s) derived from M-A549 cells and M-Panc 
cells are likely to be involved in this process. Considering the induction of 
secondary-EMT in E-cells by M-cell-CM did not affected by TGF- receptor 
kinase inhibitor (Fig. 3F), the involvement of TGF- signaling pathway is less 
likely. Collectively, these data indicate that mesenchymal-transitioned cancer 
cells-derived soluble factor(s), which is shared by A549 and Panc-1 cells, play a 
significant role in the induction of invasive ability and secondary-EMT phenotype 
in the neighboring epithelial cancer cells.  
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Figure 3. Cell-cell contact independent induction of secondary-EMT 
phenotype and invasiveness in neighboring epithelial cancer cells by 
mesenchymal-transitioned cancer cells. 
(A, B) A549 or Panc-1 cells were co-cultured directly (A) or separately in transwell 
cell culture chamber (B) at the indicated cell numbers for 24 hr and EMT-related 
protein expression were determined by western blotting. Both arrows indicate 
vimentin expression. No cells (-), E-cells (E) or M-cells (M) were seeded in upper 
compartment of transwell chamber. In the separated co-culture, the total protein 
from E-cells in lower compartment was examined. (C, D, E) E-A549 or E-Panc 
cells were treated with conditioned mediums (CM) from E-/M-A549 cells (C) or 
E-/M-Panc cells (D, E) for 48 hr and subjected to Matrigel invasion assay or 
western blotting. Both arrows indicate vimentin expression. Total invaded cells 
were counted after H & E staining. Data represented as the mean ± SD of 
triplicate experiment. **p<0.01 vs E-CM group by two-tailed student’s t test. 
 
 
(F) Effect of TGF- receptor kinase inhibitor in CMs-induced secondary-EMT 
phenotype in A549 and Panc-1 cells. E-A549 and E-Panc cells were treated with 
CMs from E-cells or M-cells for 48hr and EMT-related protein expression were 
determined by western blotting. CMs were collected form E-cells or M-cells 
culture in the presence or absence of 10 M TGF- receptor I kinase inhibitor 
(TRI) for 48 hr. 
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4.3 WNT3 and WNT5B derived from mesenchymal-transitioned cancer 
cells are the soluble factors to induce metastatic potential in the 
neighboring epithelial cancer cells.  
In order to identify the common soluble factor(s) which is secreted from 
mesenchymal-transitioned A549 and Panc-1 cells, we analyzed the published 
cDNA microarray datasets (GSE17708 and GSE23952), which represent A549 
and Panc-1 gene expression following after the TGF- stimulation for 72 or 48 hr, 
respectively. There are 55 candidate genes as top 5% of encoding secretory 
proteins that are commonly up-regulated in both A549 and Panc-1 cells (Fig. 4A 
and Table 1). By using Gene Set Enrichment Analysis, we further selected 
candidate pathway gene sets that are significantly enriched in phenotype of 
TGF- as shown in Table 2. Amongst those candidate pathways, WNT pathway 
was commonly enriched in both M-A549 and M-Panc. Thus, we further focused 
on WNT3 and WNT5B molecules in the induction of secondary-EMT in epithelial 
cancer cells. WNT3 and WNT5B are known to be a ligand for activating both 
canonical, that is mediated by -catenin/TCF transcription factor complex, and 
non-canonical WNT pathways, that is mediated by JNK or ROCK kinases [27]. 
As shown in Fig. 4B, we confirmed the higher expression of WNT3 and WNT5B 
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at protein level in both M-cells compared to E-cells. Consistent with the 
upregulation of WNT3 and WNT5B, the secretion of these WNT ligands was 
detected in CMs of M-A549 by ELISA (Fig. 4C). We also confirmed higher 
nuclear -catenin expression and -catenin transcriptional activity in E-cells with 
M-cell-CM, indicating that E-cells received the WNT signals from M-cells (Fig. 
4D and 4E).  
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Figure 4. Secretory WNT3 and WNT5B from mesenchymal-transitioned cancer 
cells induce secondary-EMT phenotype in epithelial cancer cells. 
(A) Commonly up-regulated genes encoding soluble protein in the top 5% in 
GSE17708 (Panc-1) and GSE23952 (A549) datasets were shown as Benn diagram. 
(B) Epithelial or mesenchymal-transitioned A549 or Panc-1 cells were subjected to 
western blotting to determine the expression of indicated proteins. Arrows indicate 
vimentin band. (C) Conditioned mediums from E-cells or M-cells were subjected to 
ELISA for detecting WNT3 or WNT5B. ND; not detected. 
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Figure 4. Secretory WNT3 and WNT5B from mesenchymal-transitioned cancer 
cells induce secondary-EMT phenotype in epithelial cancer cells. (continued) 
(D) 48 hr after treatment with E- or M-CM, nuclear protein was fractionated and 
subsequently subjected to western blotting for the detection of nuclear -catenin and 
Snail expression. LaminB was used as an internal control of nuclear protein. (E) 48 
hr after treatment with E- or M-CM, transcriptional activity of -catenin was 
determined by luciferase assay using TOPFlash, which contains -catenin/TCF 
binding site, and FOPFlash, which contains mutation at -catenin/TCF binding site of 
TOPFflash construct. Data represented as the mean ± SD of triplicate experiment. 
**p<0.01 vs E-CM group by two-tailed student’s t test. 
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To further examine whether WNT3 and WNT5B are responsible 
molecules in M-cell-derived CMs for the induction of invasiveness and 
secondary-EMT phenotype in E-cells, we used the siRNAs of WNT3 and 
WNT5B or the chemical WNT-ligand secretion inhibitor, IWP-2, during the 
preparation of CMs. IWP-2 directly suppresses porcupine that is required for the 
secretion of WNT ligands through palmitoylation (Chen B, et al. Nat. Chem. Biol., 
2009; 5: 100-107). The knockdown efficiencies or the inhibition of secretion were 
confirmed by qRT-PCR, western blotting and ELISA (Fig. 5A, 5B and 5C). While 
the M-cell-CM derived from single knockdown of either WNT3 or WNT5B did not 
completely diminish the induction of invasive potential and vimentin/Snail 
expression of E-A549 and E-Panc cells, the knockdown of both WNT3 and 
WNT5B completely abrogated the activity of M-cell-CM in the induction of 
invasive potential and secondary-EMT phenotype of E-A549 and E-Panc cells 
(Fig. 5D). Importantly, the M-cell-CMs prepared in the presence of IWP-2 also 
completely diminished its activity to induce invasion and secondary-EMT 
phenotype in both E-A549 and E-Panc cells (Fig. 5E and 5F). These results 
strongly indicate that WNT3 and WNT5B are likely to be key soluble factors 
produced by mesenchymal-transitioned cancer cells to instigate the metastatic 
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potential of neighboring epithelial cancer cells by enhancing their invasiveness 
and inducing secondary-EMT phenotype. 
 
 
  
Figure 5. Critical requirement of secretory WNT3 and WNT5B from 
mesenchymal-transitioned cancer cells for inducing secondary-EMT 
phenotype of epithelical cancer cells.  
(A) mRNA and protein expression in (B) cell lysate and (C) CM of WNT3 and WNT5B 
upon siRNA and TGF- treatment was determined by qPCR western blotting and 
ELISA, respectively. siRNA-treated cells were prepared according to “Material and 
Methods”. Data represented as the mean ± SD of triplicate experiments. ND; not 
detected 
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Figure 5. Critical requirement of secretory WNT3 and WNT5B from 
mesenchymal-transitioned cancer cells for inducing secondary-EMT 
phenotype of epithelical cancer cells. (Continued) 
(D) E-A549 (left) and E-Panc (right) cells were treated with WNT-depleted CMs 
derived from E- or M-cells either by siRNAs against WNT3/WNT5B for 48 hr. The 
cells were subjected to Matrigel invasion assay and western blotting. **p<0.01 by 
one-way ANOVA with Bonferroni correction. Arrows and asterisk in western blotting 
indicate vimentin and non-specific bands, respectively.  
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Figure 5. Critical requirement of secretory WNT3 and WNT5B from 
mesenchymal-transitioned cancer cells for inducing secondary-EMT 
phenotype of epithelical cancer cells. (Continued) 
(E) E-A549 (left) and E-Panc (right) cells were treated with WNT-depleted CMs 
derived from E- or M-cells either by 10 M WNT secretion inhibitor (IWP-2) for 48 hr. 
The cells were subjected to Matrigel invasion assay and western blotting. **p<0.01 
by one-way ANOVA with Bonferroni correction.(F) E-A549 or E-Panc cells were 
treated with WNT-depleted CMs derived from E-cells or M-cells by the indicated dose 
of IWP-2 for 48 hr and the expression of proteins were determined by western 
blotting. Both arrows in western blotting indicate vimentin expression 
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Finally, we have tested whether the mesenchymal-transitioned cancer 
cells can instigate metastatic spread of neighboring epithelial cancer cells 
through providing secretory WNT3 and WNT5B ligands. Consistent with the 
induction of invasiveness and secondary-EMT phenotype in vitro, the lung 
colonization of E-A549/Luc2 cells co-cultured with M-A549 cells was largely 
enhanced compare to that of E-A549/Luc2 cells co-cultured with E-A549 cells 
(Fig. 6). Such increased lung colonization was fully abrogated when 
E-A549/Luc2 cells co-cultured with M-A549 cells in the presence of IWP-2.  
  
Figure 6. Secretory WNT-dependent metastasis instigation of epithelial cancer 
cells by mesenchymal-transitioned cancer cells. 
E-A549 cells were co-cultured with either control (E-A549) cells or 
mesenchymal-transitioned A549 (M-A549) cells in the presence or absence of IWP-2 
for 48 hr and i.v. inoculated into mice. Mice were sacrificed 24 hr after the tumor 
inoculation and lungs were subjected to bioluminescent imaging to determine total 
flux (photon/sec) for lung metastasis quantification. The representative ex vivo 
images are shown. Data represented as the mean ± SEM (n=3-5). 
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Collectively, these results strongly indicate that the secretory WNT3 and 
WNT5B derived from mesenchymal-transitioned cancer cells are able to 
enhance the metastatic potential of neighboring epithelial cancer cell in vivo. 
 
 
 
  
Figure S1. The up-regulation of WNT3 and WNT5B depends on TGF--induced 
EMT in cancer cells. 
Human lung fibroblast, mouse fibroblast (NIH3T3) and Panc-1 cells were treated with 
EGF (20 ng/ml) or/and TGF- (5 ng/ml) for 48 hr. Whole cell lysate was harvested 
and subjected to western blotting for detection WNT3, 5B and Snail protein 
expression. PCNA was used as loading control. EGF is also known as EMT-inducer 
[25]. 
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5. Discussion 
 
In this study, we demonstrated the evidence that the mesenchymal-transitioned 
cancer cells instigate invasive ability and metastatic potential of the neighboring 
epithelial cancer cells in vitro and in vivo. Furthermore, we determined that 
WNT3 and WNT5B are critical factors secreted from TGF--induced 
mesenchymal cancer cells for such metastasis instigation in the epithelial cancer 
cells along with the introduction of secondary-EMT phenotype. These results 
shed the light on the significance of cancer heterogeneities within tumor 
microenvironment and the interaction between epithelial and 
mesenchymal-transitioned cancer cells in promoting metastasis disease. 
Considering the significance of in vivo metastatic ability of epithelial 
cancer cells upon co-culture with mesenchymal-transitioned cancer cells (Fig. 2 
and Fig. 6), there are additional effects on epithelial cancer cells other than 
inducing invasive ability and secondary-EMT phenotype through the secretion of 
WNT ligands by neighboring mesenchymal-transitioned cancer cells. Firstly, it is 
reported that mesenchymal-transitioned cancer cells play a unique role in 
escorting epithelial cancer cells to metastatic organ in vivo [18]. Secondly, the 
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interaction with other host stromal cells, such as platelets or fibroblasts, might be 
involved in cancer metastasis by preventing cancer cells from cellular stresses, 
inducing EMT within the blood stream [28], or leading to collective cell invasion 
through gap junctions or integrins [29, 30]. Thirdly, WNT-ligands are known to 
not only enhance the invasiveness or secondary-EMT of epithelial cancer cells 
but also affect the multiple steps in cancer metastasis and progression. Along 
with the paracrine WNT signaling as seen in this study, the autocrine WNT 
signaling of mesenchymal-transitioned cancer cells has been reported to 
contribute to the maintenance of mesenchymal phenotypes and stem cell-like 
states in breast cancer [31]. It has also reported that WNT-signaling is involved 
in the expression of matrix metalloproteinases for digesting extracellular matrix 
during intra- or extra-vasation of metastasis process [32], niche formation [33], 
and enhancement of anchorage-independent sphere formation to increase 
metastatic ability of pancreatic cancer cells [34]. Collectively, those evidences 
might implicate that not only the cell-contact independent interaction but also the 
involvement of direct cell-cell interaction between epithelial cancer cells and 
mesenchymal-transitioned cancer cells play important roles in the regulation of 
metastasis process.  
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Although WNT3 and WNT5B secreted from mesenchymal-transitioned 
cancer cells are indispensable to induce invasiveness and secondary EMT in 
neighboring epithelial cancer cells (Fig. 5), we have also identified other gene 
candidates of secretory proteins those include other known-inducers of cancer 
cell invasiveness and EMT such as CXCL12 [35], LOX/LOXL2 [36], and HB-EGF 
[37]. Those candidates of secretory proteins from mesenchymal-transitioned 
cancer cells might also contribute to induce invasiveness and secondary-EMT in 
epithelial cancer cells by cooperating with WNT-ligands therefore further studies 
should be required in this context.  
Figure 1 shows that the behavior of Snail expression over time in culture 
with TGF- is different between A549 and Panc-1 cells, suggesting that the 
mechanism of the maintenance of Snail expression and leading EMT phenotype 
could be different between both cell lines. Although the regulation of EMT 
through snail is still unclear, the paracrine system driven by the secretion of 
WNT3 and WNT5B is a common event between both TGF--induced M-A549 
and Panc-1 cells. TGF-is one of the most potent inducer of EMT (Fig. 1) and 
metastasis; however, TGF- pathway could be often genetically abrogated in 
relatively late-stage tumors because of the deletion or mutation of Smad4 
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(DPC4) or TGF- receptors [16, 17, 38]. In addition, TGF--induced EMT is 
reversible unless long-time exposure to TGF- as reported previously [39, 40]. 
We also clarified that M-cell-CM-dependent EMT was also reversible process at 
least in vitro (preliminary data). Thus, the heterogeneity of epithelial and 
mesenchymal-transitioned cancer cells might be maintained within tumor 
microenvironment through such dynamic cellular transition between E- and 
M-cell states. Considering TGF- receptor kinase inhibitor did not affect in the 
induction of invasive ability and secondary-EMT phenotype in this study (Fig. 3F), 
the paracrine WNT stimulation can be an alternative inducer of EMT and 
metastasis to TGF-in the cross-talk between mesenchymal-transitioned cancer 
cells and epithelial cancer cells. In this study, we focused on the WNT-ligands 
secreted from mesenchymal-transitioned cancer cells; however other stromal 
cells in cancer microenvironment might also produce WNT-ligands and therefore 
be involved in cancer metastasis process. Although we did not observe the 
induction of WNT3 and WNT5B by TGF- stimulation in mouse NIH3T3 
fibroblast or primary human lung fibroblasts (Fig. S1), it has been reported that 
up-regulation of WNT3A in cancer-associated fibroblasts (CAFs) could result in 
the aggressive progression of prostate tumor [41]. Besides secretion of 
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WNT-ligands, the hyperactivation of WNT signaling pathway has been observed 
in highly metastatic lung, colon adenocarcinoma [42, 43], and pancreatic cancer 
[34]. In the context of the clinical significance, WNT3 was reported to associate 
with poor prognosis of non-small cell lung cancer [44], and to promote EMT in 
HER2-overexpressing breast cancer cells [45]. Although we cannot exclude the 
possibility that WNT5B need to be coordinated with WNT3 to induce cellular 
invasion, we suggest WNT5B can solely responsible for impaired instigation 
considering non-canonical WNT pathway through WNT5B is reported to be 
involved in inducing tumor invasion [46, 47]. Furthermore, WNT5A, a paralog of 
WNT5B, and its receptor (FZD3) are known to be involved in the promotion of 
cell motility through the activation of paracrine non-canonical WNT signaling in 
skin cancer [48]. Even though IWP-2 is a pan WNT ligand secretion inhibitor, our 
presented data by knock down both WNT3 or 5B with siRNA almost completely 
diminished the activity of M-cell CM to induce invasion of E-cells therefore these 
results strongly support the critical importance of both WNT3 and 5B as WNT 
ligands secreted from M-cells to induce of E-cell invasion. Given E-cell CM in the 
presence of IWP-2 downregulated Snail or nuclear -catenin expression in 
E-A549 cells (Fig. 5D), we speculate that even E-cells may produce substantial 
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level of WNT ligand by which maintains Snail or -catenin expression of E-cells 
in an autocrine manner. Collectively, WNT-ligands derived from cancer stromal 
cells as well as mesenchymal-transitioned cancer cells and subsequent 
activation of WNT-signaling pathway may play a significant role in the malignant 
behavior of cancer cells including metastatic spread to distant organ.  
In conclusion, the intra-tumoral heterogeneity has been considered to be 
one of hallmarks in cancer malignancy and we newly identified secretory 
WNT-ligands from mesenchymal-transitioned cancer cells instigate the invasion 
of neighboring epithelial cancer cells. This novel function of WNT-signaling in 
cancer microenvironment could be an attractive target not only for the new 
therapeutic opportunity but also for the new biomarker candidate in metastatic 
disease. 
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Chapter 2: Unpublished study 
 
Chapter 2 focuses on the cross-talk between M-cells each other. Since the data 
in chapter 2 is unpublished March, 2014 now, chapter 2 is going to disclose 
when this study is published. 
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Chapter 3: Procyanidin C1 from Cinnamomi Cortex inhibits TGF--induced 
epithelial-to-mesenchymal transition in A549 lung cancer cell lines. 
 
11. Abstract 
Cancer metastasis is one of the most critical events in cancer patients, and the 
median overall survival of Stage-IIIb or -IV patients with metastatic lung cancer 
in the TNM classification is only 8 or 5 months, respectively. We previously 
identified that Juzentaihoto, a Japanese traditional medicine, can inhibit cancer 
metastasis through the activation of macrophages and T cells in mouse cancer 
metastatic models; however, it is not well known how Juzentaihoto directly 
affects tumor cells during the metastasis process and which herbal medicines 
from Juzentaihoto inhibit metastatic potential. In this study, we focus on 
epithelial-to-mesenchymal transition (EMT), which plays an important role in the 
formation of cancer metastasis. We newly determined that only Cinnamomi 
Cortex (CC) extract, one of 10 herbal medicines of Juzentaihoto, inhibits 
TGF--induced EMT. Moreover, the contents of catechin trimer in CC extracts 
were significantly correlated with the efficacy of inhibiting TGF--induced EMT. 
Finally, the structure of the catechin trimer from CC extract was chemically 
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identified as procyanidin C1 and the compound showed inhibitory activity against 
TGF--induced EMT. This illustrates that procyanidin C1 is the main active 
compound in CC extract for EMT inhibition and that procyanidin C1 could be 
useful as a lead compound to develop inhibitors of cancer metastasis and other 
diseases related to EMT. 
 
Key words: Cinnamomi cortex, epithelial-to-mesenchymal transition, lung 
cancer, procyanidin C1 
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12. Introduction 
 
The essential characteristics of cancer are the ability to invade surrounding 
tissues and metastasize to distal tissues, known as cancer metastasis, which is 
the major cause of mortality in cancer patients. In non-small-cell lung cancer 
(NSCLC) patients, the median overall survival of patients with metastatic lung 
cancer (Stage IIIb or IV in the TNM classification) is limited (only 8 or 5 months, 
respectively) [66]; therefore, suppression of cancer metastasis results in the 
improved survival of lung cancer patients. 
Cancer metastasis consists of several steps: intravasation, attachment 
to a vessel, extravasation, angiogenesis, and growth in distal tissues [67-70]. 
Among them, epithelial-to-mesenchymal transition (EMT) is involved in an early 
step of metastasis [71, 72]. EMT is a phenomenon in which cobblestone-like 
epithelial cells change into spindle-like mesenchymal cells with downregulation 
of epithelial markers such as E-cadherin and also upregulation of mesenchymal 
markers such as N-cadherin [73]. In addition to metastasis, this physiological 
phenomenon is important for resistance to apoptosis, maintenance of cancer 
stem cells and production of extracellular matrix. Thus, EMT would be an 
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attractive therapeutic target in metastatic cancers. 
Juzentaihoto, which is a Japanese Kampo medicine, has been widely 
used for the decline of physical strength, general debility, cold hands and feet, 
fatigue, night sweats, circulatory problems, and anemia [74]. Interestingly, our 
previous studies showed that Juzentaihoto indirectly inhibited cancer metastasis 
through the activation of macrophages and T cells in mouse models [75-77]. 
Although Juzentaihoto could suppress cancer metastasis, it is not well known 
how Juzentaihoto can directly affect tumor cells during the metastasis process 
and which herbal medicines of Juzentaihoto are involved in the regulation of 
EMT. 
Here we firstly report that Cinnamomi cortex (CC), one of the herbal 
medicines from Juzentaihoto, inhibits TGF--induced EMT phenotypes. After 
fractionation of CC extract, the content of catechin trimer was well-associated 
with the inhibitory activities of CC extract. Finally, procyanidin C1 from CC 
extract is newly identified as the responsible molecule for the EMT inhibition. 
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13. Materials and Methods 
 
13.1 Herbal medicine extraction  
Astagali Radix (AsR), Glycyrrhizae Radix (GlR), Cinnamomi Cortex extract (CC), 
Rehmanniae Radix (RR), Paeoniae Radix (PR), Cnidii Rhizoma (CR), Angelicae 
Radix (AnR), Ginseng Radix (GiR), Hoelen (Ho), Atractylodis Lanceae Radix 
(ALR), and Spatholobi Caulis (SC) were purchased from Uchida-Wakanyaku 
Co.,Ltd (Tokyo, Japan). In this study, Cinnamomi Cortex was added to an 
appropriate volume of distilled water (w/v, 1:10) and extracted at 100 °C for 1 
hour. The extracted solution was filtered and then freeze dried to obtain dried 
powder. A voucher sample of this extract (INM 10000007, University of Toyama) 
was preserved in the Research Promotion Office, Institute of Natural Medicine, 
University of Toyama, Toyama, Japan. Six other Cinnamomi Cortex samples 
were collected from different regions of Vietnam and China, coded as CC-1 
(Vietnam), CC-2 (Guang Xi, China), CC-3 (Guang Xi, China), CC-4 (Guang 
Dong, China), CC-5 (Guang Xi, China), CC-6 (Vietnam). Water extracts of the 
above-mentioned six CC samples were prepared and provided by the National 
Institute of Biomedical Innovation, Osaka, Japan, and a part of each extract was 
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deposited at our institute (voucher specimen no. INM 10000001-10000006). 
 
13.2 Cell Cultures 
Human lung adenocarcinoma A549 cells were cultured in RPMI Medium 1640 
(Invitrogen, Carlsbad, CA, USA) with 10 % fetal bovine serum (FBS; ICN 
Biomedicals, Aurora, OH, USA), 2 mM L-glutamine (Invitrogen), 100 units/ml 
penicillin, and 100 g/ml streptomycin in 5 % CO2 at 37 ˚C. The cells were 
treated with recombinant human TGF- (5 ng/ml) (Peprotech, London, UK) for 
various times as indicated, after pretreatment with TGF- receptor I kinase 
inhibitor (10 M) (Merck, Whitehouse, NJ, USA), each herbal medicine from 
Juzentaihoto, or Cinnamomi Cortex extracts (CC, or CC-1 to CC-6) for 30 min.  
 
13.3 Protein Preparation and Western Blotting 
Whole cell lysates were collected in lysis buffer supplemented with some 
protease and phosphatase inhibitors as described previously {Sakurai, 2003}. 
Equal amounts of protein were resolved by electrophoresis on acrylamide gels 
and transferred to PVDF membranes. Antibodies against phospho-specific 
Smad-2 (Ser 465/467), E-cadherin, and N-cadherin were purchased from Cell 
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Signaling Technology (Beverly, MA, USA) and an antibody against PCNA was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) 
 
13.4 Cell morphology and cell migration 
Cell morphology was determined by BZ-8000 (Keyence, Osaka, Japan) after 
staining with hematoxylin and eosin. For the migration assay, Transwell cell 
culture chambers were used as described previously [78]. Briefly, the filters were 
precoated with 1.25 g fibronectin on the lower surfaces. The cell suspension 
(3x104 cells/100 l) in serum-free medium was added to the upper compartment 
and incubated for 6 h. The migrated cells were stained with hematoxylin and 
eosin, and counted under the microscope in three predetermined fields at a 
magnification of x400. 
  
13.5 Fractionation of CC and identification of procyanidin C1 from CC 
CC extract 2.0 g was subjected to reversed-phase silica gel (Cosmosil 
75C18-OPN; Nacalai Tesque Inc., Kyoto, Japan) using medium pressure liquid 
chromatography (MPLC; Buchi, Flawil, Switzerland) with a H2O–CH3CN gradient 
system (98:296:492:890:1080:2060:4040:6010:90) to obtain 
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eight fractions (fr. 1, 435 mg; fr. 2, 282 mg; fr. 3, 123 mg; fr. 4, 212 mg; fr. 5, 105 
mg; fr. 6, 305 mg; fr. 7, 205 mg; fr. 8, 105 mg). The bioactive fraction 4 (fr. 4, 200 
mg) was further subjected to preparative HPLC (Discovery C18 column; 10 × 
250 mm i.d., 5 m particle size; Supelco, PA,USA) with H2O–CH3CN (92:8) 
containing 0.01% trifluoroacetic acid (TFA) at a flow rate of 2 mL/min to yield a 
procyanidin trimer (1, 5.5 mg, tR 23.3 min). The molecular formula of compound 
1 was determined by HR-TOF-MS to be C45H38O18 [m/z 865.2003 (M − H)
+]. Its 
chemical structure was further identified to be 
epicatechin-(4β→8)-catechin-(4β→8)-epicatechin (procyanidin C1, Fig. 4C) by 
comparing the [1H] nuclear magnetic resonance (NMR), [13C] NMR, and circular 
dichroism (CD) spectral data with those in the literature [79].  
 
13.6 Liquid chromatography-mass spectrometry (LC-MS) analysis 
For chemical profiling of 7 CC extracts, liquid chromatography-mass 
spectrometry (LC-MS) analysis was performed with a Shimadzu LC-IT-TOF 
mass spectrometer (Kyoto, Japan) equipped with an ESI interface (Shimadzu). 
The ESI parameters were as follows: source voltage +4.5 kV, capillary 
temperature 200 °C and nebulizer gas 1.5 l/min. The mass spectrometer was 
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operated in positive ion mode scanning from m/z 200 to 2000. A Waters Atlantis 
T3 column (2.1 mm i.d. × 150 mm, 3 m; Milford, MA, USA) was used and the 
column temperature was maintained at 40°C. The mobile phase was a binary 
eluent of (A) 5 mM ammonium acetate solution and (B) CH3CN under the 
following gradient conditions: 0-30 minute linear gradient from 10 % to 100 % B, 
30-40 min isocratic at 100 % B. The flow rate was 0.15 ml/min. Mass 
spectrometry data obtained from the extract were deposited in the MassBank 
Database and stored with pharmacological information on the extract in the 
Wakan-Yaku Database System, Institute of Natural Medicine, University of 
Toyama. 
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14. Results 
 
14.1 Cinnamomi Cortex (CC) extract suppresses TGF--induced EMT 
Our previous studies showed that Juzentaihoto, a Japanese Kampo medicine, 
prevents metastasis in mouse models [75-77]. Because Juzentaihoto contains 
ten (“Ju" means “ten” in Japanese) kinds of herbal medicines, we thus 
investigated whether each herbal medicines can suppress TGF--induced EMT. 
We firstly screened the expression of an epithelial marker, E-cadherin, in a 
human non-small-cell lung cancer cell line, A549 cells, treated with TGF-, 
TGF- receptor kinase inhibitor (TGFRi) ,which used as a positive control, or 
herbal medicines (Fig. 11A). Known as EMT, the reduction of E-cadherin 
expression in A549 cells was detected after TGF- treatment in A549 cells. 
Among the ten herbal medicines, only Cinnamomi Cortex (CC) extract strikingly 
suppressed TGF--induced EMT, as indicated by the restoration of E-cadherin. 
We could not detect any inhibition of the cell viabilities by CC extract 
In order to further determine the inhibition of TGF--induced EMT by CC 
extract, E-cadherin, N-cadherin, and phosphorylated Smad-2 were examined. 
Similarly to Fig. 11A, restoration of E-cadherin expression by CC extract was 
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detected in a concentration/time-dependent manner (Fig. 11B and 11C). 
Interestingly, phosphorylation of Smad-2 by TGF-, a downstream molecule of 
TGF- signaling, was suppressed by CC extract after the early phase (10 min, 
20 min) as well as the late phase (24 h, 48 h). We also detected the inhibition of 
TGF--induced EMT by CC extract at mRNA levels of snail, E-cadherin, and 
fibronectin (data not shown). In addition to expression levels of EMT markers, 
we observed morphological changes with CC extract (Fig. 11D). A549 cells 
treated with TGF- showed spindle-like shapes as compared with untreated 
cells. On the other hand, TGF--stimulated cells treated together with CC extract 
showed cobblestone-like shapes similar to the untreated cells or the cells with 
TGFRi and TGF-. Moreover, consistent with cell morphology, TGF--induced 
cell migration was also suppressed with CC extract (Fig. 11E). These results 
support that CC extract suppresses TGF--induced EMT in A549 cells and 
consequently inhibits cell migration. 
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Figure 11. Cinnamomi Cortex (CC) suppresses TGF--induced EMT. (Left) 
(A) Effects of ten herbal medicines from Juzentaihoto. AsR: Astagali Radix, GlR: 
Glycyrrhizae Radix, CC: Cinnamomi Cortex extract, RR: Rehmanniae Radix, PR: 
Paeoniae Radix, CR: Cnidii Rhizoma, AnR: Angelicae Radix, GiR: Ginseng Radix, 
Ho: Hoelen, ALR: Atractylodis Lanceae Radix. A549 cells were pretreated with 
various herbal medicines (100 g/ml) or TGF- receptor I kinase inhibitor (TGFRi; 10 
M) for 30 min, and stimulated with TGF- (5 ng/ml) for 48 h. Expression of each 
protein was detected by Western blotting. 
(B) Dose-dependent inhibition of TGF--induced EMT with CC treatment. A549 cells 
were pretreated with various concentrations of CC (12.5, 25, 50, 100, 200 g/ml) or 
TGF- receptor I kinase inhibitor (TGFRi; 10 M) for 30 min, and stimulated with 
TGF- (5 ng/ml) for 48 h. Expression of each protein was detected by Western 
blotting. 
(C) Time-dependent inhibition of TGF--induced EMT with CC treatment. A549 cells 
were pretreated with CC (100 g/ml) for 30 min and stimulated with TGF- (5 ng/ml) 
for the indicated times. Expression of each protein was detected by Western blotting. 
(D) Cell morphologies with CC treatment. A549 cells were stained by H&E after 
treatment as in Fig. 11C for 48 hr. 
(E) Migration with CC treatment. A549 cells treated as in Fig. 11D were seeded in 
Transwell chambers for 6 h. No. of migrated cells per field (x400) was counted. 
Relative cell migration with TGF- (TGF: filled bar), TGF- with CC extract 
(TGF+CC: shadow bar), or CC extract (CC: dotted bar) was normalized by untreated 
cell migration (open bar). Data are the mean ± S.D. of four independent experiments. 
*p<0.01, compared among each pair, by one-way ANOVA and Bonferroni’s multiple 
comparision test. 
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14.2 Identification of an active fraction inhibiting TGF--induced EMT  
To gain insight into the variations of CC extracts in EMT-inhibitory activities, we 
examined six additional CC (CC-1 to -6) extracts, which differ according to the 
harvest location (Fig. 12A). CC-2, CC-3, and CC-5 extracts showed restoration 
of E-cadherin expression stronger than CC-1, CC-4, and CC-6 extracts; 
therefore, an active component(s) for the inhibition of EMT might be included in 
CC-2, CC-3, and CC-5 extracts more than in CC-1, CC-4, and CC-6.  
To identify the active chemical compound(s) that is able to inhibit 
TGF--induced EMT, total ion chromatogram analysis was performed in CC and 
CC-1 to CC-6 extracts. Notably, the peaks of catechin-catechin-catechin trimer 
(catechin trimer) significantly overlapped with EMT inhibitory activities in CC-2, 
CC-3, and CC-5 extracts, but were not detected in CC-1, CC-4, and CC-6 
extracts (Fig. 12B), suggesting that the catechin trimer may have some crucial 
roles in suppressing TGF--induced EMT.  
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Figure 12. CCs show variability in the activity of TGF--induced EMT. 
(A) Effects of various CCs. A549 cells were pretreated with various CCs (100 g/ml), 
but other conditions were similar to Fig. 11C. Expression of each protein was 
detected by Western blotting. 
(B) Inhibition activities of CCs correlated with the content of catechin trimer. Total ion 
chromatograms (TIC) profiles of various CC extracts are shown. Arrows show the 
catechin trimer fractions. 
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14.3 Procyanidin C1 can suppress TGF--induced EMT 
Next to assess whether catechin trimer fraction of CC extract has activity to 
inhibit EMT, we examined the protein expression levels with the catechin trimer 
fraction from CC (Fig. 13A). As predicted, the catechin trimer fraction inhibited 
E-cadherin reduction and N-cadherin induction. Similarly to protein levels, the 
change of cell morphology (Fig. 13B) also supported the inhibition of 
TGF--induced EMT.  
We finally purified the catechin trimer from CC and identified its structure, 
which was an epicatechin-epicatechin-epicatechin trimer, procyanidin C1 (Fig. 
13C). To check the inhibition of EMT by procyanidin C1, the protein expression 
and cell migration activities were examined (Fig. 13D and 13E). Strikingly, EMT 
marker represented the inhibition of EMT in Western blotting, and 
TGF--induced cell migration was suppressed by procyanidin C1. 
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Figure 13. Procyanidin C1 from CC 
extract inhibits TGF--induced EMT. 
(A) Effects of catechin trimer fraction. A549 
cells were pretreated with catechin trimer at 
the indicated conc. for 30 min, but other 
conditions are similar to Fig. 11C. 
Expression of each protein was detected by 
Western blotting. (B) Cell morphologies with 
catechin trimer fraction. A549 cells were 
stained by H&E after treatment as in Fig. 
11C for 48 hr. (C) Structure of procyanidin 
C1. (D) Dose-dependent inhibition of 
TGF--induced EMT with procyanidin C1 
from CC. Other conditions were similar to 
Fig. 13A. Expression of each protein was 
detected by Western blotting. (E) Migration 
with procyanidin C1 from CC. A549 cells 
were treated as in Fig. 13C. Relative cell 
migration of the cells treated with TGF- 
(TGF: filled bar), with both TGF- and 
procyanidin C1 (shadow bar), or with 
procyanidin C1 (dotted bar) was normalized 
by untreated cells (open bar). Data are the 
mean ± S.D. of three independent 
experiments. *p<0.01, compared among 
each pair, by one-way ANOVA and 
Bonferroni’s multiple comparision test. 
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15. Discussion 
 
In this study, we firstly identified Cinnamomi Cortex (CC) extract in 10 herbal 
medicines from Juzentaihoto as the only inhibitory herbal medicine of 
TGF--induced epithelial-to-mesenchymal transition (EMT) in a human 
non-small-cell lung cancer cell line, A549 cells. The inhibitory effects of CC 
extracts could be derived from the procyanidin C1 because of the correlation of 
the content of procyanidin C1 in CC extract with their inhibitory activities. 
The inhibitory effect of CC extract on EMT phenotypes we showed here 
might be supported by the evidences of Ninjinyoeito and Keishibukuryogan, both 
of which are other Kampo medicines containing CC. Ninjinyoeito has also been 
reported to suppress cancer metastasis [80]. On the other hand, 
Keishibukuryogan has been shown to suppress renal fibrosis, which is caused 
by TGF--induced EMT [81]. Despite the inhibitory activity of CC extract, the 
possibility cannot be excluded that other herbal medicines might play a role in 
concert with CC extract, because of the harmonization effects among various 
herbal medicines [76, 77].  
Even though we identified procyanidin C1 as an active compounds for 
the inhibition of EMT, but CC extract contains various chemical compounds, 
65 
 
such as phenyl propanoids (cinnamic acid, cinnamaldehyde), terpenoids 
(cinnamonol, cassioside), and tannin (epicatechin), etc [82]. There are many 
reports about the biological activities of cinnamic acid or cinnamaldehyde, for 
example, induction of ROS-mediated apoptosis [83]. In addition, the procyanidin 
C1 we purified is known for its anti-inflammatory effects [84, 85]; however, it is 
the first time to show that procyanidin C1 has anti-metastatic or anti-EMT effects. 
Among the catechin sub-family, epigallocatechin-3 gallate in green tea has been 
reported to inhibit EMT in human melanoma cells [86, 87]. These reports raise 
the possibility that another catechin sub-family is involved in the inhibition of 
EMT besides procyanidin C1. The inhibition of cell migration by procyanidin C1 
(Fig. 13E) and the clear linkage of the amount of procyanidin C1 to the inhibition 
of TGF--induced EMT (Fig. 13A and B) suggest that procyanidin C1 is still the 
main compound in CC extracts to inhibit cell migration and EMT.  
Although we need more efforts to identify the target molecule of 
procyanidin C1, the phosphorylation of Smad-2 (Fig. 13D) and its transcriptional 
activity (data not shown) were suppressed. Indeed, CC extract and procyanidin 
C1 did not affect basal cell migration in A549 cells (CC alone or procyanidin C1 
alone in Fig. 11E and 13E), suggesting that the inhibition of EMT by CC extract 
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and procyanidin C1 is dependent on inhibition of the TGF- signal pathway and 
that mesenchymal-to-epithelial transition is not induced by CC extract or 
procyanidin C1, which might affect basal levels of cell migration.  
Collectively, our data firstly identified CC in Juzentaihoto as the only 
herbal medicine inhibiting TGF--induced EMT, which could be worthy of clinical 
study in a variety of settings associated with EMT, including cancer metastasis 
and/or tissue fibrosis. As procyanidin C1 showed inhibition of EMT, it is 
suggested that the utilization of procyanidin C1 as a lead compound would be 
attractive for the development of cancer metastasis inhibitors. Also shown in 
chapter 1 and 2, inhibition of TGF--induced EMT by procyanidin C1 could 
prevent the cross-talk between mesenchymal-transitioned cancer cells and 
surrounding cancer cells. 
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16. General conclusion 
 
This study focused on biological role of the cross-talk between 
mesenchymal-transitioned cancer cells and surrounding cancer cells on tumor 
malignant progression. Based on the results, this study is summarized below. 
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Chapter 1:  
Mesenchymal-transitioned cancer cells (M-cell) instigate epithelial cancer cells 
(E-cell) to invasion and subsequent metastasis in association with 
secondary-EMT phenotypes in WNT-dependent manner. 
 
Chapter 2:  
Unpublished 
 
Chapter 3:  
Procyanidin C1 inhibits TGF--induced EMT and could prevent subsequent 
malignant progression through cross-talks between M-cell and E-cell/M-cell. 
 
Overall, these novel findings demonstrate the dynamic regulation of EMT/MET 
within tumor microenvironment through the cross-talk between heterogeneous 
cancer cells, which leads to tumor malignant progression. 
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